Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging

M. Šuráňová, M. Ďuriš, I. Štenglová Netíková, J. Brábek, T. Horák, V. Jůzová, R. Chmelík, P. Veselý

. 2023 ; 14 (6) : 2689-2708. [pub] 20230516

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009627

Solid tumor metastases cause most cancer-related deaths. The prevention of their occurrence misses suitable anti-metastases medicines newly labeled as migrastatics. The first indication of migrastatics potential is based on an inhibition of in vitro enhanced migration of tumor cell lines. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some drugs for repurposing. The chosen Q-PHASE holographic microscope provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the pilot assessment of the migrastatic potential exerted by the chosen medicines on selected cell lines are presented.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009627
003      
CZ-PrNML
005      
20230721095524.0
007      
ta
008      
230707s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1364/BOE.488630 $2 doi
035    __
$a (PubMed)37342686
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Šuráňová, Markéta $u Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic $1 https://orcid.org/0000000182561175
245    10
$a Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging / $c M. Šuráňová, M. Ďuriš, I. Štenglová Netíková, J. Brábek, T. Horák, V. Jůzová, R. Chmelík, P. Veselý
520    9_
$a Solid tumor metastases cause most cancer-related deaths. The prevention of their occurrence misses suitable anti-metastases medicines newly labeled as migrastatics. The first indication of migrastatics potential is based on an inhibition of in vitro enhanced migration of tumor cell lines. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some drugs for repurposing. The chosen Q-PHASE holographic microscope provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the pilot assessment of the migrastatic potential exerted by the chosen medicines on selected cell lines are presented.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ďuriš, Miroslav $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic $1 https://orcid.org/0000000323831512
700    1_
$a Štenglová Netíková, Irena $u General University Hospital in Prague, Department of Clinical Pharmacology and Pharmacy, Prague, Czech Republic
700    1_
$a Brábek, Jan $u Department of Cell Biology, and Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), Laboratory of Cancer Cell Invasion, Charles University, Prague, Czech Republic
700    1_
$a Horák, Tomáš $u Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic
700    1_
$a Jůzová, Veronika $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
700    1_
$a Chmelík, Radim $u Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic $1 https://orcid.org/0000000154104794 $7 mzk2002107880
700    1_
$a Veselý, Pavel $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
773    0_
$w MED00189502 $t Biomedical optics express $x 2156-7085 $g Roč. 14, č. 6 (2023), s. 2689-2708
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37342686 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095518 $b ABA008
999    __
$a ok $b bmc $g 1958437 $s 1195891
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c 6 $d 2689-2708 $e 20230516 $i 2156-7085 $m Biomedical optics express $n Biomed Opt Express $x MED00189502
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Možnosti archivace